Biotech

All Articles

Praxis epilepsy medicine lowers seizures in phase 2 trial

.Practice Accuracy Medicines has actually scored yet another midphase gain in epilepsy this year, wi...

Three officers resign as Dyne messages mixed records for DMD candidate

.After leaving a clinical grip numerous years back, Dyne Rehab has shown new period 1/2 information ...

Arrowhead fires off stage 3 data in unusual metabolic ailment in front of market clash with Ionis

.Arrowhead Pharmaceuticals has actually presented its give in front of a potential showdown with Ion...

Pfizer, Valneva present lyme health condition go successful for second enhancer

.Pfizer as well as Valneva might have about two more years to wait prior to they help make the initi...

Fierce Biotech Editor-in-Chief Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Let's dive into a chat along with Ayla Ellison, Brutal Biotech Managing Editor and Michelle Benz as...

New data show how Bayer's asundexian stopped working to avoid movements

.Bayer suspended the phase 3 test for its own element XIa inhibitor asundexian behind time last year...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its own a number of sclerosis (MS) med tolebrutinib to th...

Galapagos' stock up as fund shows intent to shape its evolution

.Galapagos is happening under added stress from entrepreneurs. Having actually built a 9.9% risk in ...

Cell- concentrated Sana gathers very first CSO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of considerable leadership hirings, shootings...

Allist settles Jacobio $21M, landing part in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has actually gotten itself a starring role in China's KRAS market, ...